Abstract
Livers from donors after brain death (DBDs) with alcohol-associated liver disease (ALD) or steatosis, which undergo prolonged cold ischemia are often not considered for transplantation. We evaluate whether norepinephrine and acetylcholine (ACh) deficiencies impair intestinal serotonin (5-HT) delivery to the liver in extended-criteria DBDs liver transplantation (LT). A DBD rat model with ALD or severe steatosis was used. Norepinephrine, ACh and 5-HT levels were evaluated in liver and intestine. Pharmacological (ACh or 5-HT administration) and electrical stimulation of intestinal parasympathetic nervous system (IPNS) were applied to evaluate their effects on ACh, 5-HT, liver and intestinal damage. Our results indicate that norepinephrine levels were maintained in DBDs, whereas ACh and 5-HT were depleted in both intestine and liver. IPNS stimulation or ACh infusion via mesenteric artery restored intestinal ACh, generating 5-HT and intestinal protection. Platelets potentially transported this 5-HT, with restoration of hepatic 5-HT and protection. Intravenous 5-HT (not intravenous ACh) produced similar benefits, which persisted after 24 h cold ischemia and reperfusion, improving survival. Thus, IPNS electrical stimulation or ACh administration via mesenteric artery (which reversed 5-HT deficiencies in intestine and liver) or 5-HT administration can make steatotic or ALD grafts from extended-criteria DBDs viable after prolonged ischemia, improving LT outcomes.
Similar content being viewed by others
Data availability
The data supporting the findings of this study are available within the article and its supplementary information. Additional datasets are available from the corresponding author upon reasonable request.
Abbreviations
- 5-HT:
-
Serotonin
- ACh:
-
Acetylcholine
- ALD:
-
Alcoholic liver disease
- ALT:
-
Alanine aminotransferase
- AST:
-
Aspartate aminotransferase
- BD:
-
Brain death
- BDNF:
-
Brain-derived neurotrophic factor
- CI:
-
Cold ischemia
- CI/R:
-
Cold ischemia–reperfusion
- CNTF:
-
Cilliary neurotrophic factor
- DBDs:
-
Donors after brain death
- ECs:
-
Enterochromaffin cells
- H&E:
-
Hematoxylin & eosin
- HGF:
-
Hepatocyte growth factor
- IPNS:
-
Intestinal parasympathetic nervous system
- IL-10:
-
Interleukin 10
- iv:
-
Intravenous
- LT:
-
Liver transplantation
- ma:
-
Mesenteric artery
- MDA:
-
Malondialdehyde
- MPO:
-
Myeloperoxidase
- NE:
-
Norepinephrine
- PCNA:
-
Proliferating cell nuclear antigen
- SD:
-
Sprague–Dawley
- SNS:
-
Sympathetic nervous system
- TGF-β:
-
Transforming growth factor β
- TNF-α:
-
Tumor necrosis factor α
- TUNEL:
-
Terminal deoxynucleotidyl transferase dUTP nick end labeling
- UW:
-
University of Wisconsin
References
Zhou, A. L. et al. Use of Ex situ machine perfusion for liver transplantation: The national experience. Transplantation 109(6), 967–975 (2025).
Kwong, A. J. et al. OPTN/SRTR 2019 Annual Data Report: Liver. Am. J. Transplant. 21, 208–315 (2021).
Pan, E. T. et al. Cold ischemia time is an important risk factor for post-liver transplant prolonged length of stay. Liver Transpl. 24, 762–768 (2018).
Eggenhofer, E. & Proneth, B. Ferroptosis inhibition: A key opportunity for the treatment of ischemia/reperfusion injury in liver transplantation. Transplantation 109(5), e228–e236 (2025).
Tingle, S. J. et al. Donor liver blood tests and liver transplant outcomes: UK registry cohort study. Transplantation 107(12), 2533–2544 (2023).
Jiménez-Castro, M. B., Gracia-Sancho, J. & Peralta, C. Brain death and marginal grafts in liver transplantation. Cell Death Dis. 6(6), e1777 (2015).
Jiménez-Castro, M. B. et al. The effect of brain death in rat steatotic and non-steatotic liver transplantation with previous ischemic preconditioning. J. Hepatol. 62, 83–91 (2015).
Van der Hoeven, J. A. et al. Donor brain death reduces survival after transplantation in rat livers preserved for 20 hr. Transplantation 72, 1632–1636 (2001).
Gulfo, J. et al. FGF15 improves outcomes after brain dead donor liver transplantation with steatotic and non-steatotic grafts in rats. J. Hepatol. 73, 1131–1143 (2020).
Bellono, N. W. et al. Enterochromaffin cells are gut chemosensors that couple to sensory neural pathways. Cell 170, 185–198 (2017).
Lesurtel, M. et al. Platelet-derived serotonin mediates liver regeneration. Science 312, 104–107 (2006).
Choi, W. et al. Publisher correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis. Nat. Commun. 10(1), 158 (2019).
Pereboom, I. T., Lisman, T. & Porte, R. J. Platelets in liver transplantation: Friend or foe?. Liver Transpl. 14, 923–931 (2008).
Martin, C. R., Osadchiy, V., Kalani, A. & Mayer, E. A. The brain-gut-microbiome axis. Cell. Mol. Gastroenterol. Hepatol. 6, 133–148 (2018).
Fernández, L. et al. Preconditioning protects liver and lung damage in rat liver transplantation: Role of xanthine/xanthine oxidase. Hepatology 36(3), 562–572 (2002).
Cornide-Petronio, M. E. et al. The impact of cortisol in steatotic and non-steatotic liver surgery. J. Cell. Mol. Med. 21(10), 2344–2358. https://doi.org/10.1111/jcmm.13156 (2017).
van Der Hoeven, J. A. et al. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat. Ann. Surg. 232(6), 804–813. https://doi.org/10.1097/00000658-200012000-00009 (2000).
Du, B. et al. Brain death induces the alteration of liver protein expression profiles in rabbits. Int. J. Mol. Med. 34(2), 578–584. https://doi.org/10.3892/ijmm.2014.1806 (2014).
Hajiasgharzadeh, K. & Baradaran, B. Cholinergic anti-inflammatory pathway and the liver. Adv. Pharm. Bull. 7(4), 507–513. https://doi.org/10.15171/apb.2017.063 (2017).
Kelly, M. J., Breathnach, C., Tracey, K. J. & Donnelly, S. C. Manipulation of the inflammatory reflex as a therapeutic strategy. Cell Rep. Med. 3(7), 100696. https://doi.org/10.1016/j.xcrm.2022.100696 (2022).
Cornide-Petronio, M. E., Jiménez-Castro, M. B., Bujaldon, E., Gracia-Sancho, J. & Peralta, C. Hepatic Regeneration Under Warm or Cold Ischemia Conditions: Controversies and New Approaches (IntechOpen, 2018). https://doi.org/10.5772/intechopen.80340.
Rivkin, D. et al. The liver sinusoid in ischemia–reperfusion injury and regeneration. In Sinusoidal Cells in Liver Diseases: Role in Their Pathophysiology, Diagnosis, and Treatment 213–228 (2024). https://doi.org/10.1016/B978-0-323-95262-0.00010-3.
Micó-Carnero, M. et al. Relevance of the GH-VEGFB/VEGFA axis in liver grafts from brain-dead donors with alcohol-associated liver disease. Front. Cell Dev. Biol. 12, 1455258 (2025).
Mundinger, T. O., Cummings, D. E. & Taborsky, G. J. Jr. Direct stimulation of ghrelin secretion by sympathetic nerves. Endocrinology 147(6), 2893–2901 (2006).
Nocito, A. et al. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology 45, 369–376 (2007).
Álvarez-Mercado, A. I. et al. Use of steatotic grafts in liver transplantation: Current status. Liver Transpl. 25(5), 771–786 (2019).
Schmidt, N. H., Svendsen, P., Albarrán-Juárez, J., Moestrup, S. K. & Bentzon, J. F. High-fructose feeding does not induce steatosis or non-alcoholic fatty liver disease in pigs. Sci. Rep. 11(1), 2807 (2021).
Zhai, Y., Petrowsky, H., Hong, J. C., Busuttil, R. W. & Kupiec-Weglinski, J. W. Ischaemia-reperfusion injury in liver transplantation--From bench to bedside. Nat. Rev. Gastroenterol. Hepatol. 10(2), 79–89. https://doi.org/10.1038/nrgastro.2012.225 (2013).
Huang, H., Lu, Y., Zhou, T., Gu, G. & Xia, Q. Innate immune cells in immune tolerance after liver transplantation. Front. Immunol. 9, 2401. https://doi.org/10.3389/fimmu.2018.02401 (2018).
Herr, N., Bode, C. & Duerschmied, D. The effects of serotonin in immune cells. Front. Cardiovasc. Med. 4, 48. https://doi.org/10.3389/fcvm.2017.00048 (2017).
Ahern, G. P. 5-HT and the immune system. Curr. Opin. Pharmacol. 11(1), 29–33. https://doi.org/10.1016/j.coph.2011.02.004 (2011).
Shao, X. et al. A single-cell landscape of human liver transplantation reveals a pathogenic immune niche associated with early allograft dysfunction. Engineering 36, 193–208. https://doi.org/10.1016/j.eng.2023.12.004 (2024).
Lu, D. et al. Dynamic immune cell profiling identified natural killer cell shift as the key event in early allograft dysfunction after liver transplantation. Cell Prolif. 57(4), e13568. https://doi.org/10.1111/cpr.13568 (2024).
Ruddell, R. G., Mann, D. A. & Ramm, G. A. The function of serotonin within the liver. J. Hepatol. 48(4), 666–675. https://doi.org/10.1016/j.jhep.2008.01.006 (2008).
Papadimas, G. K. et al. The emerging role of serotonin in liver regeneration. Swiss Med. Wkly. 142, w13548. https://doi.org/10.4414/smw.2012.13548 (2012).
Abdel-Salam, O. M. E. et al. The 5-HT1A agonist buspirone decreases liver oxidative stress and exerts protective effect against CCl₄ toxicity. J. Exp. Clin. Toxicol. 1(1), 13–26. https://doi.org/10.14302/issn.2641-7669.ject-17-1789 (2017).
Papadimas, G. K. et al. Effect of serotonin receptor 2 blockage on liver regeneration after partial hepatectomy in the rat liver. Liver Int. 26(3), 352–361. https://doi.org/10.1111/j.1478-3231.2005.01230.x (2006).
Guseva, D. et al. Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract. Inflamm. Bowel Dis. 20(9), 1516–1529. https://doi.org/10.1097/MIB.0000000000000150 (2014).
Gharishvandi, F. et al. Involvement of 5-HT1B/1D receptors in the inflammatory response and oxidative stress in intestinal ischemia/reperfusion in rats. Eur. J. Pharmacol. 882, 173265. https://doi.org/10.1016/j.ejphar.2020.173265 (2020).
Tack, J., Janssen, P., Masaoka, T., Farré, R. & Van Oudenhove, L. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin. Gastroenterol. Hepatol. 10(11), 1239–1245. https://doi.org/10.1016/j.cgh.2012.06.036 (2012).
Tackett, J. J., Gandotra, N., Bamdad, M. C., Muise, E. D. & Cowles, R. A. Potentiation of serotonin signaling protects against intestinal ischemia and reperfusion injury in mice. Neurogastroenterol. Motil. 31(3), e13498. https://doi.org/10.1111/nmo.13498 (2019).
Tfelt-Hansen, P., De Vries, P. & Saxena, P. R. Triptans in migraine: A comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60(6), 1259–1287. https://doi.org/10.2165/00003495-200060060-00003 (2000).
Fitzgerald, L. W. et al. Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol. Pharmacol. 57(1), 75–81 (2000).
Corbett, S., Trainor, D. & Gaffney, A. Perioperative management of the organ donor after diagnosis of death using neurological criteria. BJA Educ. 21(5), 194–200. https://doi.org/10.1016/j.bjae.2021.01.001 (2021).
Shapira, M. Y. et al. Intra-arterial catheter directed therapy for severe graft-versus-host disease. Br. J. Haematol. 119(3), 760–764. https://doi.org/10.1046/j.1365-2141.2002.03923.x (2002).
Borrello, A., Agnes, A. L., Pellegrino, E., Magalini, S. & Gui, D. Targeting the rat’s small bowel: Long-term infusion into the superior mesenteric artery. J. Vis. Exp. 170, 10.3791/60787. https://doi.org/10.3791/60787 (2021).
Kochen, M. A., Andrews, S. S., Wiley, H. S., Feng, S. & Sauro, H. M. Dynamics and sensitivity of signaling pathways. Curr. Pathobiol. Rep. 10(2), 11–22. https://doi.org/10.1007/s40139-022-00230-y (2022).
Watanabe, H. et al. Peripheral serotonin enhances lipid metabolism by accelerating bile acid turnover. Endocrinology 151, 4776–4786 (2010).
Villalón, C. M. & Centurión, D. Cardiovascular responses produced by 5-hydroxytriptamine: A pharmacological update on the receptors/mechanisms involved and therapeutic implications. Naunyn Schmiedebergs Arch. Pharmacol. 376(1–2), 45–63. https://doi.org/10.1007/s00210-007-0179-1 (2007).
Watts, S. W., Morrison, S. F., Davis, R. P. & Barman, S. M. Serotonin and blood pressure regulation. Pharmacol. Rev. 64(2), 359–388 (2012).
González-Hernández, A. et al. Serotonergic modulation of vascular and endothelial function: implications for microcirculatory regulation in health and disease. Biomedicines 11(7), 1864 (2023).
Lazzeri, C., Bonizzoli, M., Guetti, C., Fulceri, G. E. & Peris, A. Hemodynamic management in brain dead donors. World J. Transpl. 11(10), 410–420. https://doi.org/10.5500/wjt.v11.i10.410 (2021).
Gunst, J. & Souter, M. J. Management of the brain-dead donor in the intensive care unit. Intensive Care Med. 50(6), 964–967. https://doi.org/10.1007/s00134-024-07409-4 (2024).
Vogel, T. et al. The 24-hour normothermic machine perfusion of discarded human liver grafts. Liver Transpl. 23(2), 207–220 (2017).
Ipsen, D. H., Lykkesfeldt, J. & Tveden-Nyborg, P. Animal models of fibrosis in nonalcoholic steatohepatitis: Do they reflect human disease?. Adv. Nutr. 11(6), 1696–1711 (2020).
Ly, M. et al. Development of a protocol for long-term ex vivo normothermic machine perfusion of rodent livers. Artif. Organs 49(9), 1394–1404. https://doi.org/10.1111/aor.15024 (2025).
Gracia-Sancho, J., Casillas-Ramírez, A. & Peralta, C. Molecular pathways in protecting the liver from ischaemia/reperfusion injury: A 2015 update. Clin. Sci. (Lond.) 129(4), 345–362 (2015).
Maria Eugenia Cornide-Petronio, Araní Casillas-Ramírez, Mónica B. Jiménez-Castro and Carmen Peralta. Experimental Brain Death Models in Liver Transplantation. In: Georgios Tsoulfas. Ed.: Organ Donation and Transplantation - Current Status and Future Challenges.
Casillas-Ramírez, A. et al. Regulation of adiponectin and resistin in liver transplantation protects grafts from extended-criteria donors. Am. J. Pathol. 195(3), 494–527 (2025).
Inoue, R. et al. Effect of a neural relay on liver regeneration in mice: Activation of serotonin release from the gastrointestinal tract. FEBS Open Bio 8, 449–460 (2018).
Acknowledgements
The authors thank Dr. Christopher Evans, a native English speaker and professional copy editor specialized in scientific research documents, for revising the English text.
Funding
Supported by the Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU) (PID2021-123123OB-100 and PID2024-155529OB-I00); the European Union (ERDF “Una manera de hacer Europa”); CERCA Programme/Generalitat de Catalunya; and the Catalan Secretaria d’Universitats i Recerca del Departament d’Economia I Coneixement (2021 SGR 01130).
Author information
Authors and Affiliations
Contributions
FS and CM-S: Investigation, Methodology, Writing–original draft, Writing–review and editing, Formal Analysis; GS, BP-S, CA and JG-S: Conceptualization, Validation, Writing–review and editing, Visualization; AC-C and MM-C: Investigation, Methodology, Writing–original draft and editing; FN-M and AG-H: Methodology and Formal Analysis; and AC-R and CP: Conceptualization, Formal Analysis, Funding acquisition, Investigation, Methodology, Resources, Supervision, Validation, Writing–original draft, Writing–review and editing.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Sanus, F., Maroto-Serrat, C., de la Rosa, G. et al. Increasing viability of pathological liver grafts from brain dead donors via intestinal parasympathetic nerve stimulation, or exogenous serotonin. Sci Rep (2026). https://doi.org/10.1038/s41598-026-47831-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-47831-w


